Note: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. For more information about sustainable investment labels, please see the FCA page linked here.
Global Equity Index Management (GE)
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
As at 31 Dec 2025
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 404 | 390 | 31 Dec 2025 |
| Median market capital | 50.5 B | 70.7 B | 31 Dec 2025 |
| 17.2 x | 17.2 x | 31 Dec 2025 | |
| 2.4 x | 2.4 x | 31 Dec 2025 | |
| 13.1% | 13.1% | 31 Dec 2025 | |
| 14.3% | 14.3% | 31 Dec 2025 | |
| Portfolio turnover rate | -18.0% | — | 31 Dec 2025 |
As at 31 Dec 2025
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 18.81% | 18.78% | 0.03% |
| Switzerland | Europe | 17.40% | 17.40% | 0.00% |
| Germany | Europe | 15.60% | 15.61% | -0.01% |
| France | Europe | 9.88% | 10.47% | -0.59% |
| Netherlands | Europe | 9.52% | 9.52% | 0.00% |
| Sweden | Europe | 6.41% | 6.41% | 0.00% |
| Spain | Europe | 5.86% | 5.86% | 0.00% |
| Italy | Europe | 5.43% | 5.43% | 0.00% |
| Denmark | Europe | 3.75% | 3.75% | 0.00% |
| Finland | Europe | 1.84% | 1.85% | -0.01% |
| Belgium | Europe | 1.73% | 1.73% | 0.00% |
| Norway | Europe | 0.85% | 0.85% | 0.00% |
| Ireland | Europe | 0.78% | 0.78% | 0.00% |
| Poland | Europe | 0.74% | 0.73% | 0.01% |
| Austria | Europe | 0.61% | 0.61% | 0.00% |
As at 31 Dec 2025
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 4.34122% | Technology | NL | £27,406,121.60 | 29,744 |
| Roche Holding AG | 2.96918% | Health Care | CH | £18,744,398.50 | 53,141 |
| AstraZeneca PLC | 2.83356% | Health Care | GB | £17,888,243.63 | 113,266 |
| Novartis AG | 2.70654% | Health Care | CH | £17,086,356.40 | 145,056 |
| SAP SE | 2.56397% | Technology | DE | £16,186,294.80 | 77,688 |
| Nestle SA | 2.56248% | Consumer Staples | CH | £16,176,912.70 | 191,160 |
| Siemens AG | 2.10182% | Industrials | DE | £13,268,759.45 | 55,483 |
| Allianz SE | 1.80522% | Financials | DE | £11,396,352.00 | 29,184 |
| Banco Santander SA | 1.78741% | Financials | ES | £11,283,908.29 | 1,120,547 |
| Novo Nordisk A/S | 1.66096% | Health Care | DK | £10,485,641.80 | 240,792 |
-
Inception date
25 Oct 2011
| Date | NAV (GBP) |
|---|---|
| 16 Jan 2026 | £235.9818 |
| 15 Jan 2026 | £236.2344 |
| 14 Jan 2026 | £235.3933 |
| 13 Jan 2026 | £234.5897 |
| 12 Jan 2026 | £235.0051 |
| 09 Jan 2026 | £234.7454 |
| 08 Jan 2026 | £233.2186 |
| 07 Jan 2026 | £232.7803 |
| 06 Jan 2026 | £232.7260 |
| 05 Jan 2026 | £231.3295 |
Distribution frequency
Quarterly
Historical performance 31 Dec 2025
2.50%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | £0.6217 | 31 Dec 2025 | 30 Dec 2025 | 15 Jan 2026 |
| Income | £0.6148 | 30 Sep 2025 | 29 Sep 2025 | 14 Oct 2025 |
| Income | £3.4934 | 30 Jun 2025 | 27 Jun 2025 | 14 Jul 2025 |
| Income | £1.0267 | 31 Mar 2025 | 28 Mar 2025 | 14 Apr 2025 |
| Income | £0.7402 | 31 Dec 2024 | 30 Dec 2024 | 15 Jan 2025 |
| Income | £0.4930 | 30 Sep 2024 | 27 Sep 2024 | 14 Oct 2024 |
| Income | £3.1891 | 28 Jun 2024 | 27 Jun 2024 | 12 Jul 2024 |
| Income | £1.2297 | 28 Mar 2024 | 27 Mar 2024 | 11 Apr 2024 |
| Income | £0.5553 | 29 Dec 2023 | 28 Dec 2023 | 15 Jan 2024 |
| Income | £0.7407 | 29 Sep 2023 | 28 Sep 2023 | 13 Oct 2023 |
Base currency: GBP